Clinical Trials on Estrogens

Total 254 results

Army Health Branch, British Army
University of East Anglia, Norwich, United Kingdom; Osteolabs, Kiel, Germany; University of Salford, Salford, United Kingdom and other collaborators

Recruiting

Effect of Oestrogen on Musculoskeletal Outcomes (E2)

Contraception | Estrogen Deficiency | Estrogen Excess

United Kingdom
Vanderbilt University Medical Center

Completed

Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension (T3PAH)

Lung Diseases | Hypertension | Pulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension | Primary Pulmonary Hypertension | Estrogens | Tamoxifen | Estrogen Receptor Antagonist | Hormone Antagonists

United States
University of Aarhus

Completed

The Anabolic Effects of Estrogen on Skeletal Muscles (ESTRO)

Estrogen Supplementation

Denmark
University of Aarhus

Completed

Effects of Fermented Red Clover on Muscle Strength and Muscle Mass

Estrogen Deficiency

Denmark
Akdeniz University

Completed

The Impact of Estrogen Administration Duration in Hormonally Prepared Frozen Embryo Transfer Cycles

Duration of Estrogen Administration

Turkey
Cedars-Sinai Medical Center

Completed

Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women

Estrogen Deficiency

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

Estrogen Replacement Therapy
Toshihiko Kono

Unknown

Comparison Between Raloxifene and Bazedoxifene

Selective Estrogen Receptor Modulator

Japan
Medical College of Wisconsin

Recruiting

Estrogen and Microvascular Function

Cardiovascular Diseases | Estrogen | Microvasculature

United States
ProofPilot
Joovv

Unknown

Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)

Testosterone Deficiency | Estrogen Deficiency

United States
National Institute of Environmental Health Sciences...

Completed

Study of Infant Diets on Estrogen Activity and Development

Infant Formula | Estrogen Activity

United States
Lawson Health Research Institute

Completed

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

Healthy | Estrogen Replacement Therapy

Canada
Health Decisions
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days (CCN013)

Focus: Estrogen-free Oral Contraception

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Estrogen Supplementation Mode in HRT-FET Cycle: a RCT

Hormone Replacement Therapy | Live Birth Rate | Estrogen
University of Colorado, Denver

Active, not recruiting

Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)

Menopause | Aging | Estrogen Deficiency | Women

United States
University of Delaware
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Impact of Estradiol on Endothelial Function in Peri-Menopausal Women

Vasodilation | Perimenopause | Estrogen

United States
University of British Columbia

Completed

The Effects of EstroSense®/MD vs Placebo in Improving the Estrogen Profile in Females

Estrogen Profile

Canada
University Hospital, Bonn

Completed

Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin (ESMory)

Oxytocin | Memory | Estrogen | Fear Extinction | Emotion Processing

Germany
Universitaire Ziekenhuizen KU Leuven

Completed

Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

Hypogonadism | Estrogens | Androgens | Testosterone
University Magna Graecia

Unknown

Autologous Platelet-Rich Plasma (PRP) and Endometrial Thickness

Endometrial Disorder | Thin Endometrium | Endometrial Thickness Not Growing Under Estrogen Stimulation

Italy
Syndax Pharmaceuticals

Completed

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer (ENCORE301)

Breast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-Positive

United States, Czechia, Canada, Hungary, Russian Federation
University of Catanzaro
University of Roma La Sapienza

Unknown

Estrogens Levels and Receptors Status and Skin Tears (ESKITE)

Estrogen Deficiency | Skin Tear

Italy
University of Colorado, Denver
National Institute on Aging (NIA)

Not yet recruiting

Cardiometabolic Consequences of the Loss of Ovarian Function (LILAC)

Menopause | Aging | Adiposity | Estrogen Deficiency

United States
Eisai Inc.

Completed

Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer

Breast Cancer | Breast Neoplasms | Cancer, Breast | Breast Cancer Female | Estrogen Receptor Positive Tumor | Breast Adenocarcinoma | ER Positive | Estrogen-receptor Positive Breast Cancer

France, United Kingdom, United States
Mackay Memorial Hospital

Not yet recruiting

Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

Menopause | Vaginal Atrophy | Platelet-rich Plasma | Estrogen Replacement Therapy
Northwestern University
National Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer Foundation

Completed

MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative

United States
University of Catanzaro

Completed

Estrogen Receptors and Chronic Venous Disease (ERCVD)

Varicose Veins | Estrogen Excess
City of Hope Medical Center
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Completed

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

Stage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma

United States
Pennington Biomedical Research Center
Louisiana Clinical and Translational Science Center

Terminated

The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause (RESUME)

Adiposity | Menopause Surgical | Estrogen Deficiency

United States
University Hospitals Cleveland Medical Center

Withdrawn

Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

Menopause | Surgery | Pelvic Floor Disorders | Estrogen

United States
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) (ARTT)

Estrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative Neoplasm

Italy
National Cancer Institute (NCI)

Terminated

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive

United States
Xiao Wang

Recruiting

Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen

Estrogen | Postmenopausal Depression

China
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaborators

Terminated

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

Stage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma

United States
University Medical Center Groningen

Terminated

Validation of [18F]FES for Imaging of Brain Estrogen Receptors

Postmenopausal | Psychiatric/Mood Disorder | Patient | Estrogen Receptor Levels | Premenopausal

Netherlands
Andrei Iagaru
General Electric

Completed

68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer

Breast Carcinoma | Estrogen Receptor Positive

United States
University of Sao Paulo General Hospital

Not yet recruiting

Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME) (ESTIME)

Menopause | Testosterone Deficiency | Estrogen Deficiency
Toshihiko Kono

Unknown

The Effects of Seasonal Changes in Osteoporosis Treatment

Selective Estrogen Receptor Modulator (SERM)

Japan
Polly A. Niravath, MD

Recruiting

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy (REVIVE)

Breast Cancer | Estrogen Receptor Positive Breast Cancer

United States
University of Pittsburgh Medical Center

Completed

Electronic Medical Record-Based Nudge to Reduce SLNB

Breast Cancer | Estrogen-receptor-positive Breast Cancer

United States
Queen Mary University of London
Hoffmann-La Roche; Asan Medical Center; Kliniken Essen-Mitte; MedSIR

Active, not recruiting

Pre-operative Immunotherapy Combination Strategies in Breast Cancer (ECLIPSE)

Breast Cancer | Estrogen Receptor-positive Breast Cancer

United Kingdom
Velindre NHS Trust
AstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLC

Active, not recruiting

Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer (FAKTION)

Estrogen Receptor Positive Breast Cancer

United Kingdom
University of Virginia

Withdrawn

COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer (Breast 51)

Breast Cancer | Estrogen Receptor-positive Breast Cancer

United States
The Methodist Hospital Research Institute
Millennium Pharmaceuticals, Inc.

Completed

TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer (ANETT)

Estrogen Receptor Positive Breast Cancer

United States
Queen Mary University of London
AstraZeneca

Unknown

A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer (MANTA)

Estrogen Receptor Positive Breast Cancer

Spain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
AHS Cancer Control Alberta

Active, not recruiting

A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (PRESTO)

Estrogen Receptor Positive Breast Cancer

Canada
Western Regional Medical Center

Terminated

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy (ABC01)

Estrogen Receptor Positive Breast Cancer

United States
Eisai Inc.

Active, not recruiting

A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Breast Neoplasms | Receptors, Estrogen | Genes, Erbb-2

United States, United Kingdom
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Terminated

Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502

Breast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor Negative

United States, Guam
University of Arizona

Completed

Estradiol Levels in Patients Treated With Estring

Estrogen Levels Among Breast Cancer Patients

United States

Clinical Trials on Estrogens

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations